A Look At Leqvio’s Lacklustre Launch

Novartis Cholesterol Drug Sales Still Stuck

The Swiss major’s CFO Harry Kirsch told Scrip that US cardiologists are slowly but surely getting to grips with the 'buy-and-bill' reimbursement model for Leqvio, while EU sales are not going to grow significantly until cardiovascular outcomes data read out in a few years’ time.

Novartis
• Source: Novartis

More from New Products

More from Scrip